Influence of CRMC dropped below 5% - Bet site
To generate a new password, please provide the email address with which you have registered to our portal before.

After clicking the “Send” button, we will send the information about generating a new password to the specified email address.
E-mail:
Please check your inbox! We have sent the information necessary for generating a new password to the specified email address.
An error has occured. There is no user in the system with the specified e-mail address.
Please provide the email address with which you have registered to our portal before.
E-mail:
Two-factor reset email successfully sent.
Failed to send the reset email.

Extraordinary Information

2010. Sep 02. 17:29
Author: EGIS Pharmaceuticals PLC
Hungarian version
Based on shareholder notification EGIS Pharmaceutical PLC announces that the Capital Research and Management Company (333 South Hope Street, Los Angeles, California, USA) reduced its holding in EGIS from 5.36% to 4.93% through the sale of 33,614 shares.

Attachments:

Original news

2010. Aug 25. 11:11 Extraordinary Information

Author: EGIS Pharmaceuticals PLC
Based on shareholder notification EGIS Pharmaceutical PLC announces that the Capital Research and Management Company (333 South Hope Street, Los Angeles, California, USA) reduced its holding in EGIS from 5.36% to 4.93% through the sale of 33,614 shares.